COMPASS Pathways plc
CMPS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816590
No open-market purchases or sales by COMPASS Pathways plc insiders were filed in the last 90 days; 224 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in COMPASS Pathways plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +2 vs. Q1 2022
- Shares held
- 6.83M
- −906.8K (−11.7%) vs. Q1 2022
- Total value
- $73.8M
- −$25.8M (−25.9%) vs. Q1 2022
- New holders
- 17
- 19 more added
- Sold out
- 15
- 26 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 224 | $1.28B |
| Q1 2026 | 194 | $511.5M |
| Q4 2025 | 168 | $379.2M |
| Q3 2025 | 157 | $318.0M |
| Q2 2025 | 140 | $145.1M |
| Q1 2025 | 135 | $148.4M |
| Q4 2024 | 132 | $117.0M |
| Q3 2024 | 130 | $206.5M |
| Q2 2024 | 122 | $172.3M |
| Q1 2024 | 116 | $228.1M |
| Q4 2023 | 126 | $201.1M |
| Q3 2023 | 113 | $164.9M |
| Q2 2023 | 97 | $68.7M |
| Q1 2023 | 103 | $81.3M |
| Q4 2022 | 111 | $61.0M |
| Q3 2022 | 115 | $80.2M |
| Q2 2022 | 108 | $73.8M |
| Q1 2022 | 109 | $99.9M |
| Q4 2021 | 126 | $167.0M |
| Q3 2021 | 118 | $228.7M |
| Q2 2021 | 111 | $294.8M |
| Q1 2021 | 83 | $182.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding COMPASS Pathways plc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Founders Fund VII Management, LLC | 278,880 | $3.02M | 6.98% | 00.0% | Unchanged |
| Rubric Capital Management LP | 283,694 | $3.07M | 0.16% | +283,694 | New |
| Susquehanna International Group, LLP | 343,739 | $3.72M | 0.01% | −75,842−18.1% | Reduced |
| Saba Capital Management, L.P. | 377,154 | $4.08M | 0.06% | +377,154 | New |
| PFM Health Sciences, LP | 392,764 | $4.25M | 0.17% | +392,764 | New |
| Morgan Stanley | 491,482 | $5.32M | 0.00% | −335,214−40.5% | Reduced |
| Agf Investments Inc. | 1,200,000 | $13.0M | 0.12% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 800 | – | – | 00.0% | Unchanged |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −898,714−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −35,323−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −21,542−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −20,400−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −17,665−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −17,625−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,120−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,338−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| TCWP LLC | 0 | $0 | 0.00% | −1,150−100.0% | Sold out |
| Private Capital Group, LLC | 0 | $0 | 0.00% | −467−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −465−100.0% | Sold out |
| Heritage Wealth Management, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Lenox Wealth Advisors, LLC | – | – | – | – | Not filed |
| SJS Investment Consulting Inc. | – | – | – | – | Not filed |